Price Alert

Deep Medicine Acquisition... (DMAQ)

NASDAQ: DMAQ · Real-Time Price · USD

2.96

-5.43 (-64.72%)

At close: Jan 31, 2024, 10:00 PM

Deep Medicine Acquisition Statistics

Share Statistics

Deep Medicine Acquisition has 4.36M shares outstanding. The number of shares has increased by 0% in one year.

Shares Outstanding	4.36M
Shares Change (YoY)	0%
Shares Change (QoQ)	0%
Owned by Institutions (%)	n/a
Shares Floating	501.86K
Failed to Deliver (FTD) Shares	245
FTD / Avg. Volume	1.72%

Short Selling Information

The latest short interest is 11.68K, so 0% of the outstanding shares have been sold short.

Short Interest	11.68K
Short % of Shares Out	n/a
Short % of Float	3.47%
Short Ratio (days to cover)	1.01

Valuation Ratios

The PE ratio is -3.92 and the forward PE ratio is null. Deep Medicine Acquisition's PEG ratio is 0.

PE Ratio	-3.92
Forward PE	n/a
PS Ratio	1.58
Forward PS	n/a
PB Ratio	-7.42
P/FCF Ratio	-8.54
PEG Ratio	0

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Deep Medicine Acquisition.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.94, with a Debt / Equity ratio of -2.28.

Current Ratio	0.94
Quick Ratio	0.79
Debt / Equity	-2.28
Debt / EBITDA	-5.03
Debt / FCF	-2.63
Interest Coverage	0.3

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$10.93M
Profits Per Employee	$-4.4M
Employee Count	2
Asset Turnover	1.28
Inventory Turnover	3.1

Taxes

Income Tax	n/a
Effective Tax Rate	0%

Stock Price Statistics

The stock price has increased by 0% in the last 52 weeks. The beta is 0.02, so Deep Medicine Acquisition's price volatility has been higher than the market average.

Beta	0.02
52-Week Price Change	n/a
50-Day Moving Average	10.76
200-Day Moving Average	11.2
Relative Strength Index (RSI)	15.43
Average Volume (20 Days)	14,214

Income Statement

In the last 12 months, Deep Medicine Acquisition had revenue of 21.86M and earned -8.8M in profits. Earnings per share was -756.01.

Revenue	21.86M
Gross Profit	14.59M
Operating Income	-2.1M
Net Income	-8.8M
EBITDA	-2.1M
EBIT	n/a
Earnings Per Share (EPS)	-756.01

Full Income Statement

Balance Sheet

The company has 10.88M in cash and 10.59M in debt, giving a net cash position of 296.19K.

Cash & Cash Equivalents	10.88M
Total Debt	10.59M
Net Cash	296.19K
Retained Earnings	-21.16M
Total Assets	20.72M
Working Capital	29.55K

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -4M and capital expenditures -36.34K, giving a free cash flow of -4.03M.

Operating Cash Flow	-4M
Capital Expenditures	-36.34K
Free Cash Flow	-4.03M
FCF Per Share	-0.35

Full Cash Flow Statement

Margins

Gross margin is 66.73%, with operating and profit margins of -9.62% and -40.24%.

Gross Margin	66.73%
Operating Margin	-9.62%
Pretax Margin	-40.24%
Profit Margin	-40.24%
EBITDA Margin	-9.62%
EBIT Margin	-9.62%
FCF Margin	-18.45%

Dividends & Yields

DMAQ does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

Currently there are no analyst rating for DMAQ.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	-2.06
Piotroski F-Score	3